New drug candidate uses novel absorption method to target cancer cells in mice
New gene variant that protects against coronary heart disease uncovered
17 August 2022The taste for specialty foods is in our genes, study shows
17 August 2022New drug candidate uses novel absorption method to target cancer cells in mice
A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut’s lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways that lead to drug resistance while increasing cancer-fighting ability and reducing side effects.
